CSL Ltd (CSLLY PINK) stock market data APIs
$79.2368
0(0%)
as of July 2, 2025
Try our APIs with
free plan!
CSL Ltd Financial Data Overview
Price chart is built with
Anychart
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Prev. Close
79.2368
Open
79.2368
High
79.2368
Low
79.0315
52 wk Range
70.22-103.2708
Market Cap
76 254 M
P/E Ratio
28.9485
Shares Outstanding
968 M
Revenue
15 230 M
EPS
4.13
Dividends (Yield)
0.0174
Beta
0.351
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CSL Ltd data using free add-ons & libraries
Get CSL Ltd Fundamental Data
CSL Ltd Fundamental data includes:
- Net Revenue: 15 230 M
- EBITDA: 4 824 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-10
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CSL Ltd News
New
ALKS or CSLLY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Alkermes (ALKS) and CSL Limited Sponsored ADR (CSLLY). But which of these two stocks pre...
WHO says thimerosal in vaccines not harmful
[WHO World Health Organization Headquarters in Geneva, Switzerland] mseidelch * A top vaccines official at the World Health Organization on Friday stated that there is no evidence to support the id...
CSL to replace Bavarian Nordic in Valneva’s vaccine deal for Germany
[Tip of fountain pen writing] Martin Barraud * French biotech Valneva SE (NASDAQ:VALN [https://seekingalpha.com/symbol/VALN]) announced Thursday a partnership with Australian company CSL Limited (O...
CDC vaccine panel recommends only thimerosal-free flu vaccines
[Small drug vial with influenza vaccine] SilverV/iStock via Getty Images The CDC's Advisory Committee on Immunization Practices voted overwhelmingly Thursday to recommend that all influenza vaccines ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
